vaccine effectiveness

16 all articles · 20 / page

Ask MedXY AI

Latest news

Tag

All articles

Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-Related Hospitalization Among US Adults Aged ≥60 Years: A Comprehensive Review

This review synthesizes current evidence on the effectiveness of adjuvanted RSVPreF3 vaccination in reducing RSV-related hospitalizations among older US adults, highlighting substantial protection across high-risk subgroups.

Section: Clinical UpdatesJul 21, 2026

Optimizing Influenza Protection in Older Adults with Diabetes: Insights from the DANFLU-2 Trial

A secondary analysis of the DANFLU-2 trial confirms that high-dose influenza vaccine significantly reduces cardiorespiratory hospitalizations in older adults with diabetes, with potentially enhanced benefits for those with longer disease du

vaccine effectiveness

Latest news

Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-Related Hospitalization Among US Adults Aged ≥60 Years: A Comprehensive Review

Optimizing Influenza Protection in Older Adults with Diabetes: Insights from the DANFLU-2 Trial

High Effectiveness and Rare Safety Risks: Real-World Meta-Analysis Validates RSV Vaccination for Older Adults

2024-2025 COVID-19 Vaccines Provide 79% Protection Against Critical Illness Despite Viral Evolution

Durability and Decay: Evaluating Long-term RSV Vaccine Effectiveness in a Large Real-World Cohort of US Veterans

High-Dose Influenza Vaccine Fails to Significantly Reduce Combined Influenza and Pneumonia Hospitalizations: Insights from the DANFLU-2 Trial

Bivalent RSV pre‑F Vaccine Dramatically Reduces RSV‑Associated Hospitalisations and Chronic‑Disease Exacerbations in Adults Aged 75–79 Years

Brand-Specific Influenza Vaccine Effectiveness in Nordic Older Adults: Insights from the 2024-2025 Season Registry-Based Target Trial Emulation

RSV prefusion F bivalent vaccine protects older adults similarly whether or not they have atherosclerotic cardiovascular disease

Effectiveness and Safety of RSV Vaccination in US Adults Aged 60 Years or Older: A Comprehensive Evidence Synthesis

How Well Do Flu Vaccines Protect Kids? A 20-Year Look at Live and Inactivated Influenza Vaccines

Updated Evidence for Covid-19, RSV, and Influenza Vaccines in the 2025-2026 Season: A Comprehensive Review

Evaluating RSV Vaccine Effectiveness Against Hospitalization in US Adults Aged 60 and Older Over Two Seasons

Maternal Bivalent Prefusion F RSV Vaccine Significantly Reduces Infant Hospitalisation in UK: Real-World Evidence from a Multicentre Study

Kidney-transplant recipients benefit from COVID-19 vaccination

Comparing the Effectiveness of Influenza Vaccines: Subunit Vaccine vs. Split-Virion Vaccine